Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 10 Show results per page	View Search Criteria \| Help With Results

Last Modified: 8/1/1998 First Published: 2/1/1998


1.		Phase III Placebo-Controlled Study of Soy Phytoestrogens in the Management of Hot Flashes in Women with a History of Breast Cancer (Summary Last Modified 08/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over				NCI				NCCTG-969258 NCI-P97-0126

Last Modified: 7/5/2006 First Published: 12/1/2001


2.		Phase III Randomized Study of Isoflavones in Reducing Risk Factors in Patients With Stage I or II Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Completed				50 to 80				NCI				MCC-0002 NCI-4031, NCI-P01-0195, NCT00027950

Last Modified: 11/21/2006 First Published: 2/20/2004


3.		Phase II Randomized Study of Soy Isoflavones Before Radical Prostatectomy in Patients With Stage I or II Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention, Treatment				Closed				18 and over				NCI				WSU-C-2418 NCT00078923

Last Modified: 5/28/2008 First Published: 6/22/2006


4.		Phase II Randomized Study of Neoadjuvant Dietary Supplementation With Soy in Patients Undergoing Radical Prostatectomy for Localized Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Closed				Over 18				NCI				CCCWFU-98203 CCCWFU-98203, CCCWFU-BG03-332, NCT00345813


5.		The Specific Role of Isoflavones in Reducing Prostate Cancer Risk

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				50 to 80				Other				MCC-12835 NCI #4031, CA 81920, NCT00617617

Last Modified: 6/1/2000 First Published: 11/1/1997


6.		Study of Metabolic Fate and Plasma Kinetics of Dietary Soy Isoflavones (Summary Last Modified 06/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Prevention				Closed				18 and over				NCI				UCMC-CHMC-91-5-3 NCI-P97-0117, NCT00003100

Last Modified: 10/15/2007 First Published: 8/1/2002


7.		Randomized Pilot Study of Isoflavones Versus Lycopene Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Completed				45 to 80				NCI				MCC-0105 NCI-3811, NCI-P02-0216, HLMCC 0105, NCT00042731

Last Modified: 10/16/2007 First Published: 6/16/2006


8.		Pilot Study of Soy-Based Meal Replacement (Almased®) as a Weight Loss Intervention in Patients With Estrogen Receptor/Progesterone Receptor-Negative Stage I-III Breast Cancer in Complete Remission

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Behavioral study, Educational/Counseling/Training, Supportive care				Closed				21 and over				NCI				CCCWFU-98904 NCT00343434


9.		Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Closed				45 and over				Other				PROS0022 97408, NCT00482157, PROS0022, NCT00482157


10.		Soy, Selenium and Breast Cancer Risk

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Prevention				Completed				35 to 50				Other				R14697 07/Q0101/10, NCT00555386

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute